Drug development is a timely and costly process, with the average cost of bringing a single new drug to market costing $1.3 billion, taking anywhere between 10-15 years to finalize complete all clinical trials. Preclinical studies are the vital first steps in research and development and is estimated to cost $7M over 73 months. Up to 35% of drugs are eliminated at phase I and II clinical trials due to toxicity.
Following our 2-part webinar series of Tips & Tricks to Better Histology, questions about histology-related issues were received from customers and answered by Leica Biosystems. Here, in Histology Tips & Tricks: Questions and Answers, Part 2, more questions are answered, specifically regarding decalcifying agents, and tissue section bubbling/cracking.
Leica biosystems BOND RX stainer can aid biomarker and drug discovery by offering fast, customized, consistent, fluorescent or chromogenic multiplex IHC and ISH on your research samples. The result? Freeing up your time to innovate, investigate and discover!
The first virtual event of the year recaptured the conference atmosphere at the Multiplex User Meeting. With Leica Biosystems total multiplex solutions and trusted partners, advances in multiplex IHC were innovatively showcased to customers via live presentations, on-demand webinars, virtual exhibition hall, networking room and, virtual lab tour!
Digital pathology is the means of capturing stained slides as high-resolution, brightfield or fluorescent images that are managed, stored, and visualized digitally. Digital pathology has several advantages over traditional microscopy that can improve project productivity and quality. This infographic highlights key benefits of implementing digital pathology in the laboratory.
Following our two-part webinar series of Tips & Tricks to Better Histology, further questions were raised by customers referring to specific issues encountered during histology/staining practice. Some of these questions are answered here to help combat issues experienced in the laboratory.